Andrew Chung Joins Harvard IQSS as Executive Fellow Focused on Venture Translation

Andrew Chung Joins Harvard IQSS as Executive Fellow Focused on Venture Translation

A full-circle moment. Thirty years ago, I launched my first venture as a Harvard student—trying to solve a real problem. That experience set the direction for everything that followed.

I’m excited to join Harvard University's Institute for Quantitative Social Science (IQSS) as an Executive Fellow, Venture Translation & Innovation, alongside my role as Founder & Managing Partner of 1955 Capital—coming back to Harvard in this capacity, working alongside faculty and students on entrepreneurship and innovation, feels like coming home.

Over the past year, I’ve had the chance to work closely with Gary King—University Professor at Harvard, one of the leading scholars in quantitative social science and a longtime builder of interdisciplinary research platforms—to help shape the IQSS Executive Fellows Program. The program brings leaders from industry, government, and the nonprofit sector into deep, project-based collaboration with faculty across the University.

My focus is venture translation: how do we take research coming out of universities like Harvard—across the social and deep sciences—and build companies that operate at global scale?

Too much of the world’s most important research is still trapped inside universities—not because the science isn’t ready, but because the systems around it aren’t designed for translation.

At a moment when traditional pathways for funding and scaling research are under increasing pressure, the gap between discovery and real-world impact is widening—not shrinking.

Breakthrough ideas risk stalling—not because the science is lacking, but because the systems to translate them don’t exist.

This builds on my work over the past 7 years on the Dean’s Advisory Cabinet at the Harvard John A. Paulson School of Engineering and Applied Sciences with Dean David Parkes and former Dean Frank Doyle, where I’ve focused on early-stage venture formation from lab-based research—and draws directly on the experience, capital, and network we’ve built at 1955 Capital.

The goal is to build and test new models at the intersection of academia and venture—working across institutions to help world-class research more consistently become real-world impact.

Grateful to Harvard's Chief Technology Development Officer Sam Liss for making the introduction to Gary that started all of this.

If you’re working on this problem—from the academic, startup, or institutional side—I’d love to connect.

Perspective: What My 12-Year-Old's Ascent of the Grand Teton Taught Me About Building Companies

Perspective: What My 12-Year-Old's Ascent of the Grand Teton Taught Me About Building Companies

My 12-year-old Aria just became the youngest climber ever guided by Exum to summit the Grand Teton via Carman’s Pinnacle—a technical variation many seasoned guides haven’t done. High exposure. No shortcuts. Zero room for ego. Exactly the environment where you see how people think under pressure.

Many climbers spend years preparing for the Grand. The peak rises 13,775 feet and demands 7,000 vertical feet of hiking, scrambles, multi-pitch climbing, and camping in freezing temps. Its routes require advanced rope skills and judgment when the margin for error narrows to inches.

Watching Aria on that terrain, I saw the same traits that define exceptional founders and how they approach risk, preparation, and “impossible” goals…

Noah Medical Expands Clinical Evidence for the Galaxy System with Two New Studies

Noah Medical Expands Clinical Evidence for the Galaxy System with Two New Studies

Medical robotics innovator Noah Medical presented two new data sets highlighting the clinical and economic performance of the company’s Galaxy System, a next-generation Robotic-Assisted Bronchoscopy platform. The studies, presented at the CHEST 2025 Annual Meeting of the American College of Chest Physicians in Chicago, validate the Galaxy System’s Embedded Imaging Technology demonstrating consistent diagnostic performance and efficiency in tertiary care institutions, academic and community hospitals, where access to advanced technology is rapidly expanding.

Craif Selected to Join Johnson & Johnson’s JLABS San Diego –

Craif Selected to Join Johnson & Johnson’s JLABS San Diego –

Craif Inc., a bio-AI startup dedicated to early cancer detection, announced that it has established its first U.S. business office in San Diego, California, located within JLABS San Diego, a global life sciences incubation facility operated by Johnson & Johnson Innovation. This milestone follows the establishment of Craif’s U.S. legal entity in 2022 and the opening of its R&D lab in Irvine, California, in February 2025. With this latest development, Craif is further accelerating its efforts to build a globally scalable model for early cancer detection.

Ampaire First to Achieve FAA G-1 Certification Basis for Hybrid Electric Propulsion System

Ampaire First to Achieve FAA G-1 Certification Basis for Hybrid Electric Propulsion System

Ampaire Inc., a leader in hybrid electric aircraft technology, announced today that the Federal Aviation Administration (FAA) has approved the G-1 Issue Paper for its AMP-H570 hybrid electric propulsion system. This approval establishes the airworthiness and environmental standards required for FAA Supplemental Type Certification, marking a significant milestone toward commercial deployment of Ampaire's hybrid electric solutions.

Nature’s Fynd Wins Prestigious NEXTY Award for Dairy-Free Fy™ Yogurt

Nature’s Fynd Wins Prestigious NEXTY Award for Dairy-Free Fy™ Yogurt

Nature’s Fynd, a food company making delicious dairy and meat alternatives with Fy™, a nutritional fungi protein, has been named the winner of the 2025 NEXTY Awards for its Dairy-Free Strawberry Fy™ Yogurt in the Dairy Alternative category. The NEXTY Awards, presented at Natural Products Expo West, are one of the most respected honors in the natural products industry, recognizing products that demonstrate exceptional innovation, integrity, and the ability to drive meaningful change.

Smithsonian: How a Microbe From Yellowstone’s Hot Springs Could Help Feed the World

Smithsonian: How a Microbe From Yellowstone’s Hot Springs Could Help Feed the World

When the startup launched its first products in February 2021, Kozubal and Jones knew they wanted Nature’s Fynd to be a one-stop shop. So they started with a Fy Breakfast Bundle, which included dairy-free cream cheese and meatless breakfast patties. “Some people would say that’s a little crazy that you would try to do both, but the reality is no different from what the cow has been doing for a pretty long time,” Jonas says. The bundle was available on their website for $14.99, shipping to 48 states. They have since grown to sell their products at over 1,000 stores across the United States, including Whole Foods.

500th Use of Noah Medical's Galaxy System Conducted at CHI Memorial

500th Use of Noah Medical's Galaxy System Conducted at CHI Memorial

The 500th use of Noah Medical’s Galaxy System in the United States was conducted at CHI Memorial in Chattanooga by Dr. Krish Bhadra. CHI Memorial is also the first hospital in Tennessee to adopt the Galaxy technology. The procedure marks an important step for Noah in the commercial rollout of its image-integrated robotic assisted bronchoscopy system in the U.S.

Designed in collaboration with physicians, the Galaxy System features a groundbreaking combination of innovative new technologies and features, including proprietary integrated tomosynthesis (TiLT+ Technology™) with augmented fluoroscopy, a disposable single-use bronchoscope with always-on vision, and a small, compact footprint that allows for easy integration into most bronchoscopy suites. Recent results have shown the Galaxy Systems’ ability to achieve 100% successful navigation to lesion, 100% diagnostic yield and 95% tool-in-lesion accuracy in a preclinical trial, and 100% tool-in-lesion accuracy and 90-95% diagnostic yield in a human trial.

World’s First Fungi-Based Yogurt from Nature’s Fynd Launching At Whole Foods Market Stores Nationally

World’s First Fungi-Based Yogurt from Nature’s Fynd Launching At Whole Foods Market Stores Nationally

Nature’s Fynd has launched their new-to-the-world product at Whole Foods Market stores nationwide. Fy Yogurt offers a delicious alternative to traditional and plant-based yogurts by using Fy, a sustainable fungi protein, as the base instead of cow milk, nuts, oats, or soy like other brands. This is the third product line in the brand’s retail portfolio, which also includes Dairy-Free Cream Cheese and Meatless Fy Breakfast Patties. All three lines will be available nationally at the organic and natural foods grocer later this month.

Perspective: What an Evening with Charlie Munger Taught Me About Venture Capital

Perspective: What an Evening with Charlie Munger Taught Me About Venture Capital

Charlie Munger, Warren Buffett’s partner & Vice Chair of Berkshire Hathaway, has died at 99. He invited me for a private dinner to exchange ideas - despite his disdain for VCs - and I found a kindred spirit and mentor who I wished I had met years sooner.

On humility & mentorship. Charlie asked about my upbringing and those who changed my life. I was an anchor baby for uneducated hardworking immigrants who escaped communism. Charlie believed in the strength and tenacity from humble origins. I told him of the Princeton physicist who taught me math for 10 years, a chance encounter with Jim Hildebrandt (founder of Bain Capital Asia), my hosting of Vinod Khosla at #TieCon. Charlie felt those fit his maxims of “when the student is ready, the teacher will come” and “opportunity meeting the prepared mind.”

On VC investing. In demystifying why Charlie invited me, I felt newfound resolve in 1955 Capital’s take on VC…

Blood testing startup Vital Biosciences collects $48M

Blood testing startup Vital Biosciences collects $48M

Ontario-based blood testing upstart Vital Biosciences revealed it has $48 million in funding, including a fresh $18.56 million Series A round led by Lachy Groom and Northpond Ventures. Lest readers forget the initial premise of Theranos, the company's initial goal was laudable: Disrupt the $74 billion lab testing industry controlled by behemoths Quest and LabCorp, and put preventive care in patients' hands.

Noah Medical Raises $150M Series B to Scale Endoluminal Robotics Solutions

Noah Medical Raises $150M Series B to Scale Endoluminal Robotics Solutions

Noah Medical has raised $150 million in Series B funding. With participation from a number of well-known institutional and strategic investors, Noah Medical will use the funds to meet rising demand for the Galaxy System, its next-generation, integrated solution for navigated robotic bronchoscopy. The oversubscribed round included investments from Softbank Vision Fund, Prosperity7 Ventures, Tiger Global, Hillhouse, Sequoia China, Shangbay Capital, Uphonest Capital, Sunmed Capital, Lyfe Capital, 1955 Capital, AME cloud ventures, as well as undisclosed strategic investors.

The announcement of this infusion of capital follows a series of recent milestone achievements for the Galaxy System™, which is designed to improve location accuracy and successful diagnosis of lung nodules using its proprietary TiLT+ Technology™. Already having received high marks from interventional pulmonologists who tested the system over the prior year, Noah Medical recently announced the platform received FDA clearance for commercial use in the United States and that it has initiated first-in-human trials at Macquarie University Hospital in Sydney, Australia.

Perspective: How Gordon Moore Helped Shape My View on Innovation

Perspective: How Gordon Moore Helped Shape My View on Innovation

Gordon Moore, co-founder of Intel Corporation, has died at 94. It's hard to express Gordon’s impact in ushering in an era where microchips are in everyday devices everywhere, from laptops to phones to children’s toys. A talk with Gordon years ago helped shape my view on innovation. Read my perspective on how predictable experience curves (like Moore’s Law) united in novel ways can create unpredictable outcomes and wildly successful products.

Noah Medical's Galaxy System Receives FDA Clearance for Robotic Navigated Bronchoscopy

Noah Medical's  Galaxy System Receives FDA Clearance for Robotic Navigated Bronchoscopy

Medical robotics innovator Noah Medical today announced FDA clearance of the Galaxy System. The Galaxy System and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures. Noah’s platform is the only Robotic navigated bronchoscopy system on the market to integrate real-time tomosynthesis and utilize a disposable bronchoscope, ushering in a new era in lung nodule biopsy.

Vogue: Will Space-Age Protein Powder Change the Future of Food?

Vogue: Will Space-Age Protein Powder Change the Future of Food?

On the corner of 51st and Seventh Avenue in Manhattan, the aroma of charcoal-​burnished lamb hangs enticingly in the winter air above Midtown’s halal carts. Alas, I can’t stop for a snack. I have a reservation down the block at Le Bernardin, that temple of pristine French seafood helmed by Eric Ripert. Tonight, however, I’m not going for the delicate skate wing or sea trout. Ripert is the first chef in New York City to be cooking with Nature’s Fynd, which is not seafood at all, but a protein fermented from an extremophilic fungal microbe (Fusarium strain flavolapis or “yellow stone,” nicknamed Fy) discovered by NASA-funded scientists in an acidic hot spring in Yellowstone National Park.

Harvard and 1955 Capital Collaborate to Launch Surgical Robotics Startup

Harvard and 1955 Capital Collaborate to Launch Surgical Robotics Startup

When a tiny mechanical insect achieved flight in the summer of 2012, its wafer-thin wings flapping almost invisibly at a rate of 120 times per second, it was the culmination of an ambitious engineering effort.

The first controlled flight of the RoboBee in the Harvard Microrobotics Lab of Prof. Robert Wood, relied on hard-won breakthroughs in design, materials, and manufacturing.

DDM Systems Partnering with GE on $4.2M ARPA-E Award for Decarbonization Tech

DDM Systems Partnering with GE on $4.2M ARPA-E Award for Decarbonization Tech

This project collaboration between DDM Systems and GE Gas Power will develop and combine key elements of casting technology including an innovative furnace development, as well as 3D printed additive ceramic mold technologies that will fundamentally change the production of high-value metal components for gas turbines. The new system could produce cast parts using up to 90% less energy than traditional methods, as well as provide improved quality, consistency, and yield, all at lower cost.

Ampaire Flies Longest Ever Nonstop Hybrid-Electric Aircraft Mission

Ampaire Flies Longest Ever Nonstop Hybrid-Electric Aircraft Mission

Ampaire's hybrid-electric EEL demonstrator aircraft completed a 1,880 statute mile (3,025 km) trip from Los Angeles to Oshkosh, Wisconsin. Ampaire says the trip "included the single longest nonstop flight ever made by a hybrid-electric aircraft - 1,135 miles." The trip started from California's Camarillo Airport with a short 85-mile repositioning flight, before resuming on Thursday with the 1,135-mile sector to Hays Airport in Kansas. Ampaire says the EEL demonstrated fuel savings of up to 40% versus a standard Cessna Skymaster, the aircraft on which it is based.

Ampaire Nets Order for Up to 250 Electric Aircraft Conversions

Ampaire Nets Order for Up to 250 Electric Aircraft Conversions

Electric propulsion start-up Ampaire has secured a launch order from air mobility firm WingTips for an initial 25 nine-seat Eco Caravans – a hybrid conversion of Cessna’s popular turboprop – in a deal that anticipates a huge follow-on deal for up to 225 aircraft.